Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $17.38 million. The enterprise value is $14.44 million.
| Market Cap | 17.38M |
| Enterprise Value | 14.44M |
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNRX has 838,976 shares outstanding. The number of shares has increased by 416.87% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 838,976 |
| Shares Change (YoY) | +416.87% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.82% |
| Owned by Institutions (%) | 3.86% |
| Float | 727,429 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04
| Current Ratio | 1.04 |
| Quick Ratio | 0.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -651.40% and return on invested capital (ROIC) is -181.28%.
| Return on Equity (ROE) | -651.40% |
| Return on Assets (ROA) | -99.47% |
| Return on Invested Capital (ROIC) | -181.28% |
| Return on Capital Employed (ROCE) | -2,150.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.75M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.50% in the last 52 weeks. The beta is 1.95, so QNRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | -0.50% |
| 50-Day Moving Average | 12.10 |
| 200-Day Moving Average | 9.32 |
| Relative Strength Index (RSI) | 67.56 |
| Average Volume (20 Days) | 1,019,223 |
Short Selling Information
| Short Interest | 130,349 |
| Short Previous Month | 22,657 |
| Short % of Shares Out | 15.54% |
| Short % of Float | 17.92% |
| Short Ratio (days to cover) | 0.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.18M |
| Pretax Income | -13.77M |
| Net Income | -13.77M |
| EBITDA | -14.08M |
| EBIT | -14.18M |
| Earnings Per Share (EPS) | -$28.39 |
Balance Sheet
The company has $5.41 million in cash and $2.47 million in debt, giving a net cash position of $2.94 million or $3.50 per share.
| Cash & Cash Equivalents | 5.41M |
| Total Debt | 2.47M |
| Net Cash | 2.94M |
| Net Cash Per Share | $3.50 |
| Equity (Book Value) | -1.21M |
| Book Value Per Share | -2.07 |
| Working Capital | 250,779 |
Cash Flow
| Operating Cash Flow | -10.74M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -416.87% |
| Shareholder Yield | n/a |
| Earnings Yield | -79.20% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:35.
| Last Split Date | Apr 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |